Carcinoma in situ of the bronchus or lung is a form of pre-cancerous condition caused by genetic mutations or environmental factors. It is associated with smoking, exposure to carcinogens (such as asbestos), radiation exposure, and family history.
Diagnosis of carcinoma in situ of the bronchus or lung can be made through a combination of tests, such as physical examination, imaging tests (such as CT scans), bronchoscopy, and biopsy.
Differential diagnosis of Carcinoma in situ of the bronchus or lung includes other forms of pre-cancerous conditions, such as bronchioloalveolar cell carcinoma and adenocarcinoma in situ.
Treatment of carcinoma in situ of the bronchus or lung is typically surgery. Radiation therapy and chemotherapy may also be used.
Prognosis for carcinoma in situ of the bronchus or lung is generally good, with approximately 90% of patients surviving 5 years or more. However, it is important to note that the prognosis is dependent on the stage of the cancer and other factors.